Curaleaf Holdings (CURLF) Cash from Investing Activities (2019 - 2024)

Curaleaf Holdings (CURLF) posted quarterly Cash from Investing Activities of -$26.0 million for Q4 2024, down 26.31% year-on-year from -$35.3 million in Q1 2024, and up 6.25% on a QoQ basis from -$27.7 million in Q3 2024.

Curaleaf Holdings (CURLF) Cash from Investing Activities (2019 - 2024) Analysis & Trends

Curaleaf Holdings (CURLF) has reported Cash from Investing Activities for 6 consecutive years, with -$26.0 million the latest figure, recorded in Q4 2024.

  • Quarterly Cash from Investing Activities fell 26.31% year-over-year to -$26.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$93.8 million (down 19.24% YoY) and the FY2025 annual result came in at -$70.3 million, up 25.03% from the prior year.
  • Cash from Investing Activities advanced to -$26.0 million in Q4 2024 per CURLF's latest filing, from -$27.7 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for CURLF reached as high as $26.7 billion in Q2 2023 and fell as low as -$26.7 billion in Q1 2023.
  • A 5-year average of -$34.5 million and a median of -$32.4 million in 2021 frame the typical range for Cash from Investing Activities.
  • Annual changes were most pronounced in 2021 — Cash from Investing Activities sank 88207.28% — and 2023, when it jumped 80175.16%.
  • Year by year, Cash from Investing Activities stood at -$26.7 million in 2020, then slumped by 211.2% to -$83.1 million in 2021, then jumped by 54.1% to -$38.1 million in 2022, then surged by 46.06% to -$20.6 million in 2023, then slipped by 26.31% to -$26.0 million in 2024.
  • According to Business Quant data, Cash from Investing Activities over the past three periods registered -$26.0 million, -$27.7 million, and $17.5 billion for Q4 2024, Q3 2024, and Q2 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Haleon 89.91 Bn 88.04 Bn - -
2 Teva Pharmaceutical Industries 35.91 Bn 32.17 Bn 1.97 Bn 229.00 Mn
3 Zoetis 32.54 Bn 30.60 Bn 1.62 Bn -87.00 Mn
4 Takeda Pharmaceutical 27.54 Bn 23.48 Bn 4.39 Bn -369.95 Mn
5 United Therapeutics 23.05 Bn 20.89 Bn 648.10 Mn 743.70 Mn
6 RedHill Biopharma 21.48 Bn 21.48 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 277.40 Mn
8 Neurocrine Biosciences 17.82 Bn 16.50 Bn 800.70 Mn -506.20 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -60.00 Mn
10 Curaleaf Holdings 6.90 Bn 6.90 Bn 157.29 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 -25.99 Mn
Dec 31, 2024 -25.99 Mn
Sep 30, 2024 -27.72 Mn
Sep 30, 2024 -27.72 Mn
Jun 30, 2024 17.51 Bn
Jun 30, 2024 17.51 Bn
Mar 31, 2024 -17.55 Bn
Mar 31, 2024 -17.55 Bn
Dec 31, 2023 -20.58 Mn
Dec 31, 2023 -20.58 Mn
Sep 30, 2023 -20.17 Mn
Sep 30, 2023 -20.17 Mn
Jun 30, 2023 26.69 Bn
Jun 30, 2023 26.69 Bn
Mar 31, 2023 -26.73 Bn
Mar 31, 2023 -26.73 Bn
Dec 31, 2022 -38.15 Mn
Dec 31, 2022 -38.15 Mn
Sep 30, 2022 -42.11 Mn
Sep 30, 2022 -42.11 Mn